Budesonide 相關新聞
Budesonide 目前有 1 則相關新聞報導,預測適應症 20 個。
本頁整合 Budesonide 的 AI 預測適應症與最新健康新聞,橘色標示的適應症表示近期有相關新聞報導。
藥物資訊
- 原適應症:Jorveza is indicated for the treatment of eosinophilic esophagitis (EoE) in adults (older than 18 years of age).
- 證據等級:L5
- 預測適應症(20 個):
- atopic eczema(100.0%)
- allergic asthma(99.9%)
- intrinsic asthma(99.9%)
- bronchitis(99.8%)
- dermatitis, atopic(99.8%)
- polyp of vocal cord(99.7%)
- polyp of middle ear(99.7%)
- epulis(99.7%)
- fibroepithelial polyp(99.7%)
- uterine polyp(99.7%)
- polyp of frontal sinus(99.7%)
- polyp of external auditory canal(99.7%)
- polyp of vulva(99.7%)
- polyp of ureter(99.7%)
- neoplastic polyp(99.7%)
- 2-hydroxyethyl methacrylate sensitization(99.6%)
- asthma(99.5%)
- Crohn's colitis(99.3%)
- inflammatory bowel disease(99.2%)
- anus disease(99.0%)
相關新聞(1 則)
Aktualisierte S2k-Leitlinie COPD 2026: Individualisierte Pharmakotherapie im Fokus - Gelbe Liste
2026-04-27 copd
來源:Gelbe Liste
免責聲明:本頁新聞由系統自動收集,僅供研究參考,不構成醫療建議。